A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
Eli Lilly and Company
Eli Lilly and Company
Sun Yat-sen University
Rutgers, The State University of New Jersey
SCRI Development Innovations, LLC
Sun Yat-sen University
SWOG Cancer Research Network
Roswell Park Cancer Institute
Institut du Cancer de Montpellier - Val d'Aurelle
Hospices Civils de Lyon
Rutgers, The State University of New Jersey
Alliance for Clinical Trials in Oncology
Memorial Sloan Kettering Cancer Center
Pfizer